Journal of Clinical Endocrinology & Metabolism, Vol 80, 254-257, Copyright © 1995 by Endocrine Society

ARTICLES

Dose-response relationships for radiation-induced hyperparathyroidism

AB Schneider, TC Gierlowski, E Shore-Freedman, M Stovall, E Ron and J Lubin
Division of Endocrinology and Metabolism, Michael Reese Hospital, University of Illinois, Chicago 60616.

It has been hard to establish with certainty that radiation exposure is a risk factor for developing hyperparathyroidism. In part this is because many cases of hyperparathyroidism remain asymptomatic and escape clinical detection. We present results from a study of 2555 subjects who received external beam radiotherapy to the head and neck area for benign conditions before their 16th birthday between 1939 and 1962. The average length of follow-up was 36.6 yr. There were 36 confirmed cases of hyperparathyroidism. Based on a relative risk model, the excess relative risk increased significantly by 0.11/centigray; however, the confidence interval was wide (95% confidence interval, 0.0- 17.2). The hyperparathyroidism rates and dose-response relationships were not affected by gender or age at first radiation treatment. The demonstration of a dose-response relationship within an irradiated cohort supports an association between radiation exposure and hyperparathyroidism and suggests that the calcium levels of individuals irradiated to the head and neck area should be monitored.

This article has been cited by other articles:

				A. B. Schneider, E. Ron, J. Lubin, M. Stovall, E. Shore-Freedman, J. Tolentino, and B. J. Collins Acoustic neuromas following childhood radiation treatment for benign conditions of the head and neck Neuro-oncol, February 1, 2008; 10(1): 73 - 78. [Abstract] [Full Text] [PDF]

				J. A. Lee, M. M. Grumbach, and O. H. Clark The Optimal Treatment for Pediatric Graves' Disease Is Surgery J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 801 - 803. [Full Text] [PDF]

				T. E. Hamilton, S. Davis, L. Onstad, and K. J. Kopecky Hyperparathyroidism in Persons Exposed to Iodine-131 from the Hanford Nuclear Site J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6545 - 6548. [Abstract] [Full Text] [PDF]

				S. Conroy and B. O'Malley Hypercalcaemia in cancer BMJ, October 22, 2005; 331(7522): 954 - 954. [Full Text] [PDF]

				C. H. Read Jr., M. J. Tansey, and Y. Menda A 36-Year Retrospective Analysis of the Efficacy and Safety of Radioactive Iodine in Treating Young Graves' Patients J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4229 - 4233. [Abstract] [Full Text] [PDF]

				M. S. Momani, E. Shore-Freedman, B. J. Collins, J. Lubin, E. Ron, and A. B. Schneider Familial Concordance of Thyroid and Other Head and Neck Tumors in an Irradiated Cohort: Analysis of Contributing Factors J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2185 - 2191. [Abstract] [Full Text] [PDF]

				D. Mihailescu, E. Shore-Freedman, S. Mukani, J. Lubin, E. Ron, and A. B. Schneider Multiple Neoplasms in an Irradiated Cohort: Pattern of Occurrence and Relationship to Thyroid Cancer Outcome J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3236 - 3241. [Abstract] [Full Text] [PDF]

				S. J. Marx Hyperparathyroid and Hypoparathyroid Disorders N. Engl. J. Med., December 21, 2000; 343(25): 1863 - 1875. [Full Text] [PDF]

				R. Mihai and J. R. Farndon Parathyroid disease and calcium metabolism Br. J. Anaesth., July 1, 2000; 85(1): 29 - 43. [Full Text] [PDF]

				S. A. Rivkees, C. Sklar, and M. Freemark The Management of Graves' Disease in Children, with Special Emphasis on Radioiodine Treatment J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3767 - 3776. [Full Text]

				A. B. Schneider, C. Bekerman, J. Leland, J. Rosengarten, H. Hyun, B. Collins, E. Shore-Freedman, and T. C. Gierlowski Thyroid Nodules in the Follow-Up of Irradiated Individuals: Comparison of Thyroid Ultrasound with Scanning and Palpation J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4020 - 4027. [Abstract] [Full Text] [PDF]